

Anna Richo
Director, Exelon, Ilumina, and Children’s Minnesota; Trustee, DePaul University; Former General Counsel, Cargill
Anna Richo retired from Cargill, Inc., where she was the General Counsel, Chief Compliance Officer and Corporate Secretary. In addition to her global responsibilities for law and compliance, she oversaw Global Government Relations, Global Security and Shareholder Relations, and was a member of Cargill's Executive Team. Anna was a founding member of Cargill’s ESG and Sustainability Committee. With a law career spanning more than 35 years, Anna wore multiple hats and has extensive experience in compliance and business ethics, intellectual property and corporate litigation.
Before joining Cargill, Anna was Executive Vice President and General Counsel at UCB, a biopharmaceutical company based in Belgium, where she resided for many years. She also served as senior vice president and chief compliance officer at Amgen, a global biotechnology firm, and as chief litigation counsel, associate general counsel and vice president of law at Baxter Healthcare. Her broad international experience extends throughout Europe, Latin America and Asia and has served to strengthen her commitment to championing diversity, equity and inclusion in the workplace.
A native New Yorker, Anna holds a Bachelor of Science degree in industrial and labor relations from Cornell University and a Juris Doctor degree from the College of Law at DePaul University. Anna is a member of the Board of Directors of Exelon Corporation (NASDAQ: EXC), the nation’s largest energy delivery company, a member of the Board of Directors of Illumina, Inc. (NASDAQ: ILMN), a global human genomics DNA sequencing company, a member of the Board of Trustees of DePaul University, and is a member of Children’s Minnesota Governance Board and Foundation Board. Anna formerly served on the Board of Directors of Adamas Pharmaceuticals, a publicly traded neurology company, from 2020-2021, subsequently acquired by Supernus Pharmaceuticals, and on the Board of Directors of Cytyc Corporation, a publicly traded medical diagnostics company, from 1998-2003, subsequently acquired by Hologic Inc. Additionally, Anna served on the Board of Directors for the California Manufacturers & Technology Association, a statewide nonprofit association, from 2000-2003, where she was Vice- Chairman of the Board.